{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:26:44Z","timestamp":1777577204477,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.vaccine.2017.10.018","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T13:46:28Z","timestamp":1508939188000},"page":"6691-6699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"PB","title":["The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells"],"prefix":"10.1016","volume":"35","author":[{"given":"Nicholas","family":"Wohlgemuth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine J.","family":"Fenstermacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Pekosz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.10.018_b0005","series-title":"Fields virology","first-page":"1151","article-title":"Orthomyxoviridae","author":"Shaw","year":"2013"},{"key":"10.1016\/j.vaccine.2017.10.018_b0010","first-page":"554","article-title":"Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A\/Ann Arbor\/6\/60 (H2N2)","volume":"167","author":"Cox","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.10.018_b0015","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1128\/JVI.62.2.488-495.1988","article-title":"Four viral genes independently contribute to attenuation of live influenza A\/Ann Arbor\/6\/60 (H2N2) cold-adapted reassortant virus vaccines","volume":"62","author":"Snyder","year":"1988","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0042-6822(02)00035-1","article-title":"Yang C-f, Kemble G, Greenberg H. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (flumist) derived from cold-adapted a\/ann arbor\/6\/60","volume":"306","author":"Jin","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.10.018_b0025","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1128\/JVI.78.2.995-998.2004","article-title":"Imparting temperature sensitivity and attenuation in ferrets to A\/Puerto Rico\/8\/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A\/Ann Arbor\/6\/60","volume":"78","author":"Jin","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0030","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.virol.2008.07.027","article-title":"The cold adapted and temperature sensitive influenza A\/Ann Arbor\/6\/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature","volume":"380","author":"Chan","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.10.018_b0035","first-page":"181","article-title":"Live attenuated influenza vaccine","volume":"386","author":"Jin","year":"2015","journal-title":"Current Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0040","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/JVI.79.3.1918-1923.2005","article-title":"Attenuating mutations of the matrix gene of influenza A\/WSN\/33 virus","volume":"79","author":"Liu","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0045","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/JCM.22.5.719-725.1985","article-title":"Attenuation of wild-type human influenza A virus by acquisition of the PA polymerase and matrix protein genes of influenza A\/Ann Arbor\/6\/60 cold-adapted donor virus","volume":"22","author":"Snyder","year":"1985","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0050","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.vaccine.2013.12.069","article-title":"Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures","volume":"32","author":"Fischer","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.018_b0055","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1016\/j.vaccine.2015.07.023","article-title":"Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells","volume":"33","author":"Fischer","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.018_b0060","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0042-6822(81)90317-2","article-title":"Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus","volume":"112","author":"Lamb","year":"1981","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.10.018_b0065","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1128\/JVI.76.3.1391-1399.2002","article-title":"Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture","volume":"76","author":"Takeda","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0070","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.cell.2010.08.029","article-title":"Influenza virus M2 protein mediates ESCRT-independent membrane scission","volume":"142","author":"Rossman","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2017.10.018_b0075","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1128\/JVI.00049-06","article-title":"The cytoplasmic tail of the influenza a virus M2 protein plays a role in viral assembly","volume":"80","author":"Iwatsuki-Horimoto","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0080","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1128\/JVI.79.6.3595-3605.2005","article-title":"The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging","volume":"79","author":"McCown","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0085","doi-asserted-by":"crossref","first-page":"8178","DOI":"10.1128\/JVI.00627-06","article-title":"Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production","volume":"80","author":"McCown","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0090","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1128\/JVI.00853-10","article-title":"Tyrosines in the influenza a virus M2 protein cytoplasmic tail are critical for production of infectious virus particles","volume":"84","author":"Grantham","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0095","doi-asserted-by":"crossref","first-page":"10059","DOI":"10.1128\/JVI.01184-08","article-title":"The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding","volume":"82","author":"Chen","year":"2008","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2017.10.018_b0100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0042-6822(91)90115-R","article-title":"Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds","volume":"183","author":"Holsinger","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.10.018_b0105","doi-asserted-by":"crossref","first-page":"12179","DOI":"10.1128\/JVI.05970-11","article-title":"Mutations in the membrane-proximal region of the influenza A virus M2 protein cytoplasmic tail have modest effects on virus replication","volume":"85","author":"Stewart","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0110","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0092-8674(92)90219-3","article-title":"Unpacking the incoming influenza virus","volume":"69","author":"Helenius","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2017.10.018_b0115","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0092-8674(92)90452-I","article-title":"Influenza virus M2 protein has ion channel activity","volume":"69","author":"Pinto","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2017.10.018_b0120","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/JVI.65.1.232-244.1991","article-title":"Transport of incoming influenza virus nucleocapsids into the nucleus","volume":"65","author":"Martin","year":"1991","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2017.10.018_b0125","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1128\/JVI.03253-14","article-title":"Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface","volume":"89","author":"Alvarado-Facundo","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.chom.2009.09.005","article-title":"Matrix protein 2 of influenza a virus blocks autophagosome fusion with lysosomes","volume":"6","author":"Gannag\u00e9","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2017.10.018_b0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.chom.2014.01.006","article-title":"A LC3-interacting motif in the influenza A virus M2 protein is required to subvert autophagy and maintain virion stability","volume":"15","author":"Beale","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2017.10.018_b0140","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1128\/JVI.00576-15","article-title":"Proton channel activity of influenza a virus matrix protein 2 contributes to autophagy arrest","volume":"90","author":"Ren","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0145","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1097\/00005537-200410000-00028","article-title":"mRNA for genes associated with antigen presentation are expressed by human middle meatal epithelial cells in culture","volume":"114","author":"Lane","year":"2004","journal-title":"Laryngoscope"},{"key":"10.1016\/j.vaccine.2017.10.018_b0150","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.otohns.2006.11.011","article-title":"Innate immunity of the sinonasal cavity and its role in chronic rhinosinusitis","volume":"136","author":"Ramanathan","year":"2007","journal-title":"Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.vaccine.2017.10.018_b0155","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2500\/ajr.2007.21.2997","article-title":"Sinonasal epithelial cell expression of toll-like receptor 9 is decreased in chronic rhinosinusitis with polyps","volume":"21","author":"Ramanathan","year":"2007","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0160","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.10.018_b0165","doi-asserted-by":"crossref","first-page":"8655","DOI":"10.1128\/JVI.01129-09","article-title":"Palmitoylation of the influenza A virus M2 protein is not required for virus replication in vitro but contributes to virus virulence","volume":"83","author":"Grantham","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0170","doi-asserted-by":"crossref","first-page":"D67","DOI":"10.1093\/nar\/gkv1276","article-title":"GenBank","volume":"44","author":"Clark","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2017.10.018_b0175","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1750-2659.2011.00331.x","article-title":"Influenza Research Database: an integrated bioinformatics resource for influenza research and surveillance","volume":"6","author":"Squires","year":"2012","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2017.10.018_b0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-61779-621-0_12","article-title":"Reverse genetics of influenza viruses","volume":"865","author":"Neumann","year":"2012","journal-title":"Methods Molecular Biol (Clifton, NJ)"},{"key":"10.1016\/j.vaccine.2017.10.018_b0185","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2017.09.058","article-title":"Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells","author":"Forero","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.018_b0195","doi-asserted-by":"crossref","first-page":"L415","DOI":"10.1152\/ajplung.00398.2015","article-title":"Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donors","volume":"310","author":"Peretz","year":"2016","journal-title":"Am J Physiol Lung Cell Molec Physiol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0200","doi-asserted-by":"crossref","first-page":"e1005840","DOI":"10.1371\/journal.ppat.1005840","article-title":"Progesterone-based therapy protects against influenza by promoting lung repair and recovery in females","volume":"12","author":"Hall","year":"2016","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.vaccine.2017.10.018_b0205","doi-asserted-by":"crossref","first-page":"9469","DOI":"10.1128\/JVI.00989-07","article-title":"The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells","volume":"81","author":"Newby","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0210","doi-asserted-by":"crossref","first-page":"11725","DOI":"10.1128\/JVI.01477-12","article-title":"Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium","volume":"86","author":"Ilyushina","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0215","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1128\/JVI.02677-05","article-title":"Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells","volume":"80","author":"Ibricevic","year":"2006","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2017.10.018_b0220","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2006.06.024","article-title":"Influenza A virus infection of primary differentiated airway epithelial cell cultures derived from Syrian golden hamsters","volume":"354","author":"Newby","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.10.018_b0225","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1165\/ajrcmb\/2.2.145","article-title":"Characterization of guinea pig tracheal epithelial cells maintained in biphasic organotypic culture: cellular composition and biochemical analysis of released glycoconjugates","volume":"2","author":"Adler","year":"1990","journal-title":"Am J Respir Cell Molec Biol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0230","doi-asserted-by":"crossref","first-page":"L1315","DOI":"10.1152\/ajplung.00169.2002","article-title":"Growth and differentiation of mouse tracheal epithelial cells: selection of a proliferative population","volume":"283","author":"You","year":"2002","journal-title":"Am J Physiol Lung Cell Molec Physiol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0235","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/icb.2012.9","article-title":"The interferons and their receptors\u2013distribution and regulation","volume":"90","author":"de Weerd","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2017.10.018_b0240","doi-asserted-by":"crossref","first-page":"e1000017","DOI":"10.1371\/journal.ppat.1000017","article-title":"IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo","volume":"4","author":"Sommereyns","year":"2008","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.vaccine.2017.10.018_b0245","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0168-1702(87)90028-1","article-title":"Temperature-sensitive defect of influenza A\/Ann Arbor\/6\/60 cold-adapted variant leads to a blockage of matrix polypeptide incorporation into the plasma membrane of the infected cells","volume":"7","author":"Odagiri","year":"1987","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2017.10.018_b0250","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2017.10.018_b0255","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.282.2.137","article-title":"Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial","volume":"282","author":"Nichol","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.10.018_b0260","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0264-410X(99)00334-5","article-title":"Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses","volume":"18","author":"Treanor","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.018_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6505a1","article-title":"Prevention and control of seasonal influenza with vaccines","volume":"65","author":"Grohskopf","year":"2016","journal-title":"MMWR Recomm Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17314147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17314147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T12:41:21Z","timestamp":1603197681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17314147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":53,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0264410X17314147"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}